These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 15593039)
1. Effect of protein leaking BK-F PMMA-based hemodialysis on plasma pentosidine levels. Tessitore N; Lapolla A; Aricò NC; Poli A; Gammaro L; Bassi A; Bedogna V; Corgnati A; Reitano R; Fedele D; Lupo A J Nephrol; 2004; 17(5):707-14. PubMed ID: 15593039 [TBL] [Abstract][Full Text] [Related]
2. Influence of hemodialysis membrane permeability on serum levels of advanced glycation end products (AGEs) and homocysteine metabolites. Klemm A; Franke C; Busch M; Müller A; Franke S; Lang D; Passlick-Deetjen J; Stein G Clin Nephrol; 2004 Mar; 61(3):191-7. PubMed ID: 15077870 [TBL] [Abstract][Full Text] [Related]
3. Glycoxidation and inflammatory markers in patients on treatment with PMMA-based protein-leaking dialyzers. Galli F; Benedetti S; Floridi A; Canestrari F; Piroddi M; Buoncristiani E; Buoncristiani U Kidney Int; 2005 Feb; 67(2):750-9. PubMed ID: 15673326 [TBL] [Abstract][Full Text] [Related]
4. Influence of hemodialysis membrane type on pentosidine plasma level, a marker of "carbonyl stress". Jadoul M; Ueda Y; Yasuda Y; Saito A; Robert A; Ishida N; Kurokawa K; Van Ypersele De Strihou C; Miyata T Kidney Int; 1999 Jun; 55(6):2487-92. PubMed ID: 10354298 [TBL] [Abstract][Full Text] [Related]
5. The effect of PMMA-based protein-leaking dialyzers on plasma homocysteine levels. Galli F; Benedetti S; Buoncristiani U; Piroddi M; Conte C; Canestrari F; Buoncristiani E; Floridi A Kidney Int; 2003 Aug; 64(2):748-55. PubMed ID: 12846775 [TBL] [Abstract][Full Text] [Related]
6. Advanced glycation end products: specific fluorescence changes of pentosidine-like compounds during short daily hemodialysis. Fagugli RM; Vanholder R; De Smet R; Selvi A; Antolini F; Lameire N; Floridi A; Buoncristiani U Int J Artif Organs; 2001 May; 24(5):256-62. PubMed ID: 11420874 [TBL] [Abstract][Full Text] [Related]
7. A new polymethylmethacrylate membrane for hemodialysis. Bonomini M; Fiederling B; Bucciarelli T; Manfrini V; Di Ilio C; Albertazzi A Int J Artif Organs; 1996 Apr; 19(4):232-9. PubMed ID: 8786174 [TBL] [Abstract][Full Text] [Related]
9. Olmesartan medoxomil is associated with decreased plasma AGEs, pentosidine, and N-(epsilon)-carboxymethyl-lysine levels in hemodialysis patients. Honda H; Hosaka N; Aoshima Y; Hirai Y; Michihata T; Akizawa T Clin Exp Hypertens; 2012; 34(1):17-23. PubMed ID: 22149003 [TBL] [Abstract][Full Text] [Related]
10. The influence of gender, weight, height and BMI on pentosidine concentrations in plasma of hemodialyzed patients. Slowick-Zylka D; Safranow K; Dziedziejko V; Dutkiewicz G; Ciechanowski K; Chlubek D J Nephrol; 2006; 19(1):65-9. PubMed ID: 16523428 [TBL] [Abstract][Full Text] [Related]
11. Uraemic itching: do polymethylmethacrylate dialysis membranes play a role? Aucella F; Vigilante M; Gesuete A; Maruccio G; Specchio A; Gesualdo L Nephrol Dial Transplant; 2007 Jul; 22 Suppl 5():v8-12. PubMed ID: 17586845 [TBL] [Abstract][Full Text] [Related]
12. The effect of dialysis membrane type on plasma concentrations of pentosidine, a marker of carbonyl stress, in hemodialyzed patients. Słowik-Zyłka D; Safranow K; Dziedziejko V; Ciechanowski K; Dziewanowski K; Chlubek D Pol Arch Med Wewn; 2009 Oct; 119(10):614-20. PubMed ID: 19847136 [TBL] [Abstract][Full Text] [Related]
13. Association of serum pentosidine with arterial stiffness in hemodialysis patients. Zhou Y; Yu Z; Jia H; Sun F; Ma L; Guo R; Peng L; Cui T Artif Organs; 2010 Mar; 34(3):193-9. PubMed ID: 20447043 [TBL] [Abstract][Full Text] [Related]
14. Circulating levels and dietary intake of the advanced glycation end-product marker carboxymethyl lysine in chronic kidney disease patients on conservative predialysis therapy: a pilot study. Piroddi M; Palazzetti I; Quintaliani G; Pilolli F; Montaldi M; Valentina V; Libetta C; Galli F J Ren Nutr; 2011 Jul; 21(4):329-39. PubMed ID: 21193322 [TBL] [Abstract][Full Text] [Related]
15. Plasma pentosidine and total homocysteine levels in relation to change in common carotid intima-media area in the first year of dialysis therapy. Suliman ME; Stenvinkel P; Jogestrand T; Maruyama Y; Qureshi AR; Bárány P; Heimbürger O; Lindholm B Clin Nephrol; 2006 Dec; 66(6):418-25. PubMed ID: 17176913 [TBL] [Abstract][Full Text] [Related]
16. [Comparison of the hemodialysis adequacy conducted based on low-flux polysulfone dialyzers and high-flux helixone dialyzers]. Sobaszek-Pitas M; Kopeć J; Krzanowski M; Sułowicz W Przegl Lek; 2014; 71(7):384-8. PubMed ID: 25338334 [TBL] [Abstract][Full Text] [Related]
17. Effect of the super-flux cellulose triacetate dialyser membrane on the removal of non-protein-bound and protein-bound uraemic solutes. De Smet R; Dhondt A; Eloot S; Galli F; Waterloos MA; Vanholder R Nephrol Dial Transplant; 2007 Jul; 22(7):2006-12. PubMed ID: 17468506 [TBL] [Abstract][Full Text] [Related]
18. The relationship between pentosidine and hemodialysis-related connective tissue disorders. Sakata S; Takahashi M; Kushida K; Oikawa M; Hoshino H; Denda M; Inoue T Nephron; 1998; 78(3):260-5. PubMed ID: 9546683 [TBL] [Abstract][Full Text] [Related]
19. Ultrapure dialysate reduces plasma levels of beta2-microglobulin and pentosidine in hemodialysis patients. Furuya R; Kumagai H; Takahashi M; Sano K; Hishida A Blood Purif; 2005; 23(4):311-6. PubMed ID: 15980621 [TBL] [Abstract][Full Text] [Related]
20. Plasma dimethylarginine levels in chronic hemodialysis patients are independent of the type of dialyzer applied. Grooteman MP; Wauters IM; Teerlink T; Twisk JW; Nubé MJ Blood Purif; 2007; 25(3):281-9. PubMed ID: 17622710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]